On CNBC's “Halftime Report Final Trades,” on Monday, Amy Raskin, chief investment officer at Chevy Chase Trust, named Ascendis Pharma A/S (NASDAQ:ASND) as her final trade.According to recent news, the U.S. Food & Drug Administration (FDA) on Nov. 25 extended the review period for Ascendis Pharma's New Drug Application (NDA) for TransCon CNP (navepegritide) for children with achondroplasia. The FDA said the information submitted on Nov. 5, related to the post-marketing requirement constituted a major amendme ...

Group 1 - The article provides a top-down analysis of the consumer discretionary sector, focusing on industry metrics related to value, quality, and momentum [1] - It aims to assist in analyzing sector ETFs, such as the iShares US Consumer Discretionary ETF [1] - The analysis is part of a monthly series that may highlight potential investment opportunities within the sector [1] Group 2 - The author, Fred Piard, has over 30 years of experience in technology and has been investing in data-driven systematic strategies since 2010 [1] - Fred runs an investing group that shares a portfolio invested in quality dividend stocks and companies at the forefront of tech innovation [1] - The author also provides market risk indicators and various investment strategies, including real estate, bonds, and closed-end funds [1]